Report Categories
View AllRecent Articles
View All
Lu Pulls Back Market Rotation Hits Real Estate 20260403 1
Southwest SWX Relative Performance Q4 2025 Profit Exceeds Views
Archimedes 3 ARCI Stock Valuation Metrics Overview 010 20260418
The one metric that defines Brookdale BKD success Volatility Increases 20260507
Is Wave Life WVE stock gaining upward traction Wave Life Sciences Posts 10 Negative EPS Surprise
DFSC DEFSEC revenue surges 2286 percent YoY defying EPS miss shares rally 1127 percent on growth optimism
Why Floor FND valuation makes sense when you dig deeper Eye on Rally 20260505
Newmont Corporation NEM Wall Street Analysts Flag Precious Metals Leader as Top Sector Buy Following Stellar Q1 2026 Results
Real Asset RAAQ reports inaugural quarterly results as newly public company CEO emphasizes acquisition pipeline growth
SP 500 Edges Higher as Healthcare and Tech Lead Gains
Beyond to Acquire Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond
Nvidias PostEarnings Dip The Broader Context Sellers May Be Overlooking
Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions Oil Edges Lower
April Jobs Report Preview Labor Market Cooling but Showing Resilience Amid Economic Challenges
XOVR ETF Hyperscaler AI Capex in Focus Ahead of Summer 2026 Earnings
FTAIM Q1 2026 Earnings Preferred Dividend Coverage in Focus After EPS Miss
BLFY Q3 2025 Earnings EPS Misses Estimates as Revenue Picture Remains Opaque
VAALCO Energy EGY Q1 2026 Earnings Deep Loss Surprises Market Amid Operational Challenges
Arrive AI Inc ARAI Q1 2026 Earnings EPS Surpasses Estimates but Stock Slips 71
Seer Inc SEER Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline
DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech
General American Investors GAM Posts Modest Gain Holds Near Resistance
Southwest Gas Holdings SWX Edges Higher as Utility Sector Draws Steady Demand
FMY Sees Modest Uptick Amid Stabilizing Mortgage Income Fund Performance
InfuSystems Holdings INFU Faces Pressure as Shares Slide 23 Support Test Ahead
Astera Labs ALAB Edges Higher Navigating Key Support and Resistance Levels
CSRS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges
ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status
ADCT Q1 2026 Earnings EPS Beat Amid Revenue Absence
CPSH Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap
Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss